Clinical trial
Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines
NCT00197288 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00197288 |
|---|---|
| Title | Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines |
| Official title | A Phase III, Observer-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix™ (GlaxoSmithKline Biologicals) Compared With Fluzone® (Aventis Pasteur) Administered Intramuscularly in Adults 18 Years and Older in the U.S. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Influenza |
| Enrollment | 1,847 |
| Start date | Oct 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 18, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: